Jacqueline Dianne Corry

Title: Jacqueline Dianne Corry: Innovator in Respiratory Syncytial Virus Research

Introduction

Jacqueline Dianne Corry is a prominent inventor based in Columbus, OH (US). She has made significant contributions to the field of virology, particularly in the study of respiratory syncytial virus (RSV). Her innovative work has implications for vaccine development and immunogenic compositions.

Latest Patents

Jacqueline Dianne Corry holds a patent for a respiratory syncytial virus having cleavage-resistant G protein and related materials and methods. This patent outlines compositions, methods, and uses for RSV and immunogenic compositions. The embodiments disclosed provide RSV with cleavage-resistant mutated attachment (G) glycoproteins, which enhance the production of live attenuated RSV in host cells. Additionally, the patent includes methods for amplifying RSV in host cells, resulting in amplified RSV with full-length G protein. These advancements are crucial for formulating immunogenic compositions, including vaccines, and for inducing effective immune responses against RSV infection in subjects.

Career Highlights

Jacqueline Dianne Corry is affiliated with Nationwide Children's Hospital, where she conducts her research. Her work is instrumental in advancing the understanding of RSV and developing potential therapeutic solutions.

Collaborations

Some of her notable coworkers include Mark Edward Peeples and Steven A. Kwilas, who contribute to her research endeavors and collaborative projects.

Conclusion

Jacqueline Dianne Corry's innovative research on respiratory syncytial virus has the potential to significantly impact vaccine development and public health. Her contributions to the field exemplify the importance of scientific innovation in addressing viral infections.